Research
Case reports
Durable tumour responses following primary high dose induction with mistletoe extracts: Two case reports
M. Orange , A. Fonseca, A. Lace, H.B. von Laue H B & S. Geider
European Journal of Integrative Medicine Volume 2, Issue 2, June 2010, Pages 63–69
Reports tumour regression in 2 patients following treatment with Mistletoe extracts, used in higher than generally doses and combining different applications.
M. Orange , A. Fonseca, A. Lace, H.B. von Laue H B & S. Geider
European Journal of Integrative Medicine Volume 2, Issue 2, June 2010, Pages 63–69
Reports tumour regression in 2 patients following treatment with Mistletoe extracts, used in higher than generally doses and combining different applications.
Durable Regression of primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe treatment: Two Case Reports
M. Orange, A. Lace, M. P. Fonseca, B. H. von Laue, S. Geider & G. S. Kienle.
Global Advances in Health and Medicine March 2012 Vol1 No1
Reports that high dose, fever-fever mistletoe treatment seems to have beneficial effects in two cases of primary cutaneous B-cell lymphoma.
M. Orange, A. Lace, M. P. Fonseca, B. H. von Laue, S. Geider & G. S. Kienle.
Global Advances in Health and Medicine March 2012 Vol1 No1
Reports that high dose, fever-fever mistletoe treatment seems to have beneficial effects in two cases of primary cutaneous B-cell lymphoma.
Systematic reviews
Horneber M, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology.
Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD003297. DOI: 10.1002/14651858.CD003297.pub2
Kienle GS, Kiene H. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts.
Eur J Med Res 2007; 12(3):103-119.
Further research and scientific information
For more research /scientific information on Mistletoe therapy see the Die Mistel website.
